Provided by Tiger Trade Technology Pte. Ltd.

Foghorn Therapeutics Inc.

5.74
-0.2600-4.33%
Volume:305.42K
Turnover:1.77M
Market Cap:340.87M
PE:-5.89
High:5.97
Open:5.96
Low:5.73
Close:6.00
52wk High:7.61
52wk Low:3.27
Shares:59.39M
Float Shares:28.08M
Volume Ratio:0.84
T/O Rate:1.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9742
EPS(LYR):-1.1800
ROE:-470.38%
ROA:-19.92%
PB:-4.21
PE(LYR):-4.86

Loading ...

Jun 15, 2021

Major Issues Report

8-K - Current report
Jun 01, 2021

Major Issues Report

8-K - Current report
May 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 29, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 28, 2021

Major Issues Report

8-K - Current report
Apr 19, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 23, 2021

Major Issues Report

8-K - Current report
Mar 18, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 18, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Major Issues Report

8-K - Current report
Feb 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 15, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Dec 04, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Dec 04, 2020

Major Issues Report

8-K - Current report
Nov 25, 2020

Major Issues Report

8-K - Current report
Oct 29, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Oct 27, 2020

Major Issues Report

8-K - Current report
Oct 22, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 20, 2020

Correspondence

CORRESP [Cover] - Correspondence